Prehistoric Egypt Corpus: The Corpus of Prehistoric Pottery and Palettes

Book of research on prehistoric pottery. Contains illustrations for identifying pottery.https://knowledge.e.southern.edu/kweeks_coll/1033/thumbnail.jp

Ancient Egypt 1915 Part 3

Part 3 of the 1915 Ancient Egypt books. Contents include Ta Tehenu - olive land, multiple souls in Africa, leaden tokens, the Stone Age in Egypt, and boat names in Egypt.https://knowledge.e.southern.edu/kweeks_coll/1003/thumbnail.jp

Naukratis: Part I., 1884-5

Book recording the excavations and findings at Naukratis.https://knowledge.e.southern.edu/kweeks_coll/1035/thumbnail.jp

Comportamento vegetativo e produtivo da videira e composição da uva em São Joaquim, Santa Catarina

O objetivo deste trabalho foi avaliar o comportamento vegetativo e produtivo das variedades de videira Cabernet Sauvignon, Merlot e Sauvignon Blanc, e a composição da uva em São Joaquim, Santa Catarina. Foram avaliadas plantas de um vinhedo comercial, cultivado em espaldeira, a 1.293 m de altitude, durante os ciclos fenológicos 2005/2006 e 2006/2007. As variáveis meteorológicas, a fenologia, o desenvolvimento do dossel e a composição da uva na colheita foram comparados entre os ciclos. As temperaturas mais amenas influenciaram o ciclo fenológico das variedades Cabernet Sauvignon, Merlot e Sauvignon Blanc, que é mais longo e tardio que nas outras regiões vitícolas do Brasil. Houve influência significativa da precipitação pluvial sobre a maturação da uva, no ciclo 2006/2007. Os índices de desenvolvimento indicam a necessidade de ajuste no manejo do dossel para um maior equilíbrio entre o crescimento vegetativo e a produção. As variedades Cabernet Sauvignon, Merlot e Sauvignon Blanc apresentam elevada qualidade da uva no momento da colheita, sendo adequadas ao cultivo em São Joaquim, SC

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Researches in Sinai

Book on archaeological research in Sinai.https://knowledge.e.southern.edu/kweeks_coll/1034/thumbnail.jp